1. AstraZeneca quits cancer pipeline efforts — Eisai's weight loss drug is pulled from market due to safety concerns — Melinta seeks buyout bids to escape bankruptcy — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Novartis could settle for $1B as part of federal kickback lawsuit: report

Discussion in 'Whistleblower News' started by cafead, May 16, 2019 at 12:23 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    14,034
    Likes Received:
    3
    Six years after federal prosecutors first targeted Novartis for an alleged kickback scheme involving $10,000 dinners and fishing trips for doctors, signs pointed to the Swiss drugmaker finally having its day in court. Now it looks like that may not happen.


    Novartis could be approaching a billion-dollar settlement with the U.S. government as part of a whistleblower lawsuit accusing the company of bribing doctors to boost subscriptions of its drugs, sources told STAT.

    https://www.fiercepharma.com/pharma...e-for-1b-as-part-federal-kickback-lawuit-stat